Sean Arlauckas

Sean Arlauckas

Company: Be Biopharma

Job title: Director - B Cell Platform

Seminars:

Developing Ex Vivo Precision Gene Engineered B Cell Medicines to Create Sustainable Anti-Tumor Activity & Overcome Pharmacokinetic Shortcomings of BiTEs 2:30 pm

Exploring BiTE-expressing BECMs associated with reduced tumor burden in patientderived xenograft models Achieving clinically meaningful serum levels of BiTERead more

day: Conference Day 2

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.